WallStreetZenWallStreetZen

NASDAQ: ACTU
Actuate Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Actuate Therapeutics earnings were -$20.5M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ACTU earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$4.9M, down 13.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ACTU reported annual earnings of -$22.2M, with -18.5% growth. The next ACTU earnings date is Nov 12, 2026.

ACTU earnings history

Current Revenue
$0.0
Current Earnings
-$20.5M
Current Profit Margin
0%

ACTU Return on Equity

Current Company
-346.2%
Current Industry
-13.6%
Current Market
30.9%
ACTU's Return on Equity (-346.2%)... subscribe to Premium to read more.
High Return on Equity Performance

ACTU Return on Assets

Current Company
-178.4%
Current Industry
-10.3%
ACTU is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ACTU announces earnings.

ACTU Return on Capital Employed

Current Company
-1,465.67%
Current Industry
-7%

ACTU vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ACTU-$20.43M-$20.45MN/A-$0.87
KRSA-$6.71M-$6.71MN/A-$11.67
COCP-$9.89M-$9.94MN/A-$0.76
ESLA-$10.01M-$10.01MN/A-$0.24
CLRB-$22.30M-$22.32MN/A-$3.84
View Top Biotech Stocks

ACTU earnings dates

Next earnings date
Nov 12, 2026

Actuate Therapeutics Earnings Reports & History FAQ

What were Actuate Therapeutics's earnings last quarter?

On ACTU's earnings call on Aug 13, 2026, Actuate Therapeutics (NASDAQ: ACTU) reported Q2 2026 earnings per share (EPS) of -$0.20, up 33.33% year over year. Total ACTU earnings for the quarter were -$4.87 million. In the same quarter last year, Actuate Therapeutics's earnings per share (EPS) was -$0.30.

If you're new to stock investing, here's how to buy Actuate Therapeutics stock.

When does Actuate Therapeutics report earnings?

The next ACTU earnings date is Nov 12, 2026. Add ACTU to your watchlist to be reminded of Actuate Therapeutics's next earnings date.

Is Actuate Therapeutics profitable or losing money?

As of the last Actuate Therapeutics earnings report, Actuate Therapeutics is currently losing money. Actuate Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$20.45 million, a 17.14% decrease year over year.

What was ACTU's earnings growth in the past year?

As of Actuate Therapeutics's earnings date in Aug 13, 2026, Actuate Therapeutics's earnings has grown year over year. ACTU earnings in the past year totalled -$20.45 million.

What are Actuate Therapeutics's earnings expectations?

The current EPS estimate for Actuate Therapeutics's earnings report in Nov 12, 2026 is -$0.18.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.